Ascletis Pharma Inc (HKEX: 1672), a China-based, R&D driven biotech company, announced on Sunday that it has named John P. Gargiulo as its new chief business officer.
In the new role, Gargiulo is to head the company's corporate business development and alliance management and report to Dr Jinzi J. Wu, PhD, of Ascletis founder, chairman and CEO.
Gargiulo has served as North America president and CEO of Daiichi Sankyo. He has more than 30 years of experience in marketing strategies, business integration and commercial operations in the global pharma/biotech industry. He has served in various positions with increasing responsibility for 18 years at Daiichi Sankyo.
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Enable Biosciences names new chief financial officer
Cadenza Bio names new director
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation